James
Toner, MD, Atlanta
Center for Reproductive Medicine,
100 Stone Forest Drive, suite 300
Woodstock, GA 30189, USA
(770) 928-2276
(The
full text of this article with graphs and references
is available in Acrobat format.)
Both
quantitative and qualitative factors regarding egg
production are strong influences on IVF outcome. Markers
of ovarian reserve such as basal FSH, (CCCT), and
antral follicle counts are good predictors of the
quantity of eggs which can be induced to grow. However,
the quality of those eggs seems better predicted by
the age of the women. In women past age 40, current
success rates are low overall, even in those who good
ovarian reserve who make many eggs; at this age, quantity
does not make up for quality.
By
contrast, young women with limited ovarian reserve
can have good success rates despite their limited
cohort of eggs, because the eggs themselves are of
high potential; here quality matters more than quantity.
The ramifications of these observations include the
following: Diminished ovarian reserve should not be
used as an exclusionary criterion in young women,
because overall they still have satisfactory pregnancy
rates, though their risk of cancellation is increased.
In women past age 40, normal ovarian reserve testing
is not reassuring because even reduced egg quality
is likely to limit the opportunity for successful
pregnancy no matter how many eggs are available.
Fifteen
years ago Muasher and colleagues from the Norfolk
IVF program reported that basal FSH levels predicted
ovarian response and pregnancy outcome in IVF cycles
[1]. Since then more than a hundred articles have
sought to refine our understanding of the link between
markers of "ovarian reserve" and pregnancy
in ART. And while there have been important refinements
to our original understanding of the concept of ovarian
reserve, the essence of the initial message has only
been confirmed in the numerous studies that followed.
In this article we will consider the biological basis
for the links among the markers of ovarian reserve,
the reserve itself, and the pregnancy potential. We
will also review the original and newer elements of
this understanding.
Women
make all the eggs they will ever have before they
are born. This supply begins to be depleted before
birth, and continues until menopause, when the endowment
is gone (Fig. 1). Most studies have suggested that
the rate of egg loss is essentially constant over
a women's life span, although several reports have
detected an accelerated rate of loss at around age
37 years on average. This means that at the beginning
of every menstrual cycle, a relatively fixed proportion
of all the remaining eggs becomes 'recruitable,' i.e.,
sensitive to gonadotropins. Given that the overall
number of eggs in younger women is higher than at
later years, the size of the 'cohort' of recruitable
eggs in younger women is much larger.
As
the size of the egg endowment decreases with age,
certain predictable concomitants have been observed.
These include physical manifestations, such as smaller
ovaries and fewer antral follicles, but also hormonal
events, such as elevations of basal FSH and shorter
follicular phases [2,3]. Morris [4] has confirmed
that the number of visible antral follicles on ultrasound
correlates with the actual number in the primordial
follicle pool.
Another
feature of follicle depletion relates to the expected
pattern of FSH rise. While 'basal' (i.e., days 2 to
5 of the menstrual cycle) FSH fluctuates somewhat
from cycle to cycle, we can distinguish 3 phases:
1. Up until the time when egg supply begins to become
limited, basal FSH is never elevated. 2. Once menopause
is well established, basal FSH is always elevated.
3. During the intermediate stage, FSH is sometimes
elevated and sometimes normal (Fig. 2). During this
phase, however, fecundity is reduced whether or not
the FSH is elevated during a particular cycle or not.
Several studies have demonstrated that the ovarian
response and pregnancy rate in cycles with normal
FSH is not normal if any prior cycle displayed an
abnormal FSH.
Many
elements of the initial reports are still valid, including:
1. High age is limiting even with normal FSH.
Original reports demonstrated lower pregnancy rates
in women past 40 years of age, no matter their basal
FSH level [5]. Even with today's treatments, successful
pregnancies past age 42 are uncommon, and past 45
are rare.
2. High FSH is limiting even with normal age.
The original reports saw a declining pregnancy rate
as FSH rose above 20, and no ongoing pregnancies beyond
an FSH of 25 IU/L [5,6]. While the assay has since
changed and altered these cutoffs, there still tends
to be a threshold above which declining performance
(egg production and pregnancy rate) is detected, and
a higher threshold above which egg production is quite
limited, and almost no pregnancies have occurred.
3. Cutoffs for FSH depend on the lab test employed.
Up through the early 1990's, most commercial assays
reported FSH levels about twice as high as those now
in wide use. Thus, whereas the cutoff of normal FSH
was 20 IU/L in early reports, it is now more commonly
about 10 IU/L. And whereas markedly abnormal ovarian
reserve was formerly seen only above 25 IU/L, now
that threshold occurs above about 15 IU/L. It is still
best if clinics develop their own thresholds to define
then end of the normal range, and the entry into the
very abnormal range, for FSH and estradiol assays
commonly employed for their patients.
4. The highest-ever FSH is the one most likely
to be true. Several early reports demonstrated the
futility of delaying treatments until a cycle with
a normal FSH occurs. More recent studies have continued
to affirm this effect [7,8]. Once an FSH elevation
is observed, egg production capacity will be limited
thereafter. This is to be expected, given the on-again,
off-again nature of basal FSH elevations once egg
numbers become critically short (as illustrated in
Fig. 2).
5. Prediction of ovarian reserve is easier
than predicting pregnancy. Basal FSH levels are better
able to predict outcomes more closely related to ovarian
function, such as cancellation (R2=77%), follicles
aspirated (R2=35%), and oocytes retrieved (R2=21%)
than more distal events such as pregnancy rate (R2=4%)
[5,9].
1. High age and high FSH affect delivery rates but in
different ways. FSH is the better predictor of the
number of eggs that can be induced to grow by gonadotropin
administration, and consequently cancellation rate
[10-14]. Age, on the other hand, is the better predictor
of embryo implantation and miscarriage rate [11,14-16].
Since prospects for delivery are affected by both
quantitative and qualitative deficiencies in eggs,
both age and FSH are important (Fig. 3).
Initial
claims (by this author) that FSH was more predictive
of outcome than age, and similar subsequent claims,
reflects a lack of understanding that both ovarian
reserve and age are important. The apparent strength
of one over the other in any particular study has
more to do with the operating range of FSH and age
in the cases under study than in any underlying physiological
principle. Furthermore, at extremes of either age
or FSH (e.g., age >45 years, FSH >20 IU/L),
fertility is essentially nil [17-20]. In one large
study of IVF patients, FSH >14.2 IU/L was associated
with a very low pregnancy rate (2.7% and a high miscarriage
rate (71.4%) which persisted even among women below
age 35 years [21]. Annual reports of U.S. ART live
born delivery rates in women over age 43 years are
chronically under 3% per attempt. Clearly both factors
are important predictors.
2. Young women with moderate elevations of FSH will make
fewer eggs, and run a high risk of cycle cancellation,
but if eggs are retrieved, they have reasonable chances
for pregnancy. This 'protective' effect of young age
was not seen in the original study (Toner 91), but
has been seen repeatedly since [22-25].
For
example, the van Rooij study [23] noted that in women
under age 40 with elevated FSH, the risk for cancellation
was high, but the pregnancy rate among those proceeding
to transfer was good (Table I).
In
another informative study [26], mild elevations of
FSH predicted the need for more stimulation to get
an acceptable ovarian response. Even with this adjustment,
a lower response was in evidence, but enough eggs
were produced to achieve a roughly equivalent transfer
and pregnancy rate (Table II). However, as FSH became
more elevated, pregnancy rates fell as stimulation
adjustments were unable to compensate for diminished
ovarian responsiveness.
It
is also important to note that while FSH (and related
endocrine or ultrasound markers) are the best available
predictors of the quantity of eggs that can be produced,
the actual number produced is more meaningful to outcome
that the prediction. Thus studies that focus on cycles
in which only a few eggs are produced show low success
rates even at young ages [27] (Table III).
The
strength of the relation between basal hormone markers
and ovarian reserve is enhanced with luteal estradiol
administration [28].
The
combined effect of age and FSH on ultimate delivery
rate is illustrated in the following Figure 4. Note
that women beyond age 42 are unlikely to deliver no
matter what their basal FSH might be; this reflects
the significant reduction in egg quality (i.e., implantation
potential) which is nearly universally seen at this
age independent of predicted or actual ovarian responsiveness.
Also note that while younger women's success is heavily
dependent on basal FSH, only when the FSH is markedly
elevated (typically above 20 IU/L) will their chances
as low as the women in their mid-forties.
3.
Other markers of ovarian reserve: